Cancer Gene Therapy - Table of Contents alert Volume 19 Issue 11

TABLE OF CONTENTS Volume 19, Issue 11 (November 2012) In this issue Reviews Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nurture your career with the new-look Naturejobs As the world's largest dedicated jobs boards for the scientific community, Naturejobs is the ideal resource to build your career. Our new and improved functionality enables you to search, save and apply for jobs quickly and easily. Search over 10,000 vacancies to find exactly the right job for you at: www.naturejobs.com   Reviews Top MicroRNAs involved in regulating epithelial–mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics H Xia and K M Hui Cancer Gene Ther 2012 19: 723-730; advance online publication, September 14, 2012; 10.1038/cgt.2012.58 Abstract | Full Text Bacterial vectors for imaging and cancer gene therapy: a review M Cronin, R M Stanton, K P Francis and M Tangney Cancer Gene Ther 2012 19: 731-740; advance online publication, September 21, 2012; 10.1038/cgt.2012.59 Abstract | Full Text A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy J Park, K Singha, S Son, J Kim, R Namgung, C-O Yun and W J Kim Cancer Gene Ther 2012 19: 741-748; advance online publication, September 28, 2012; 10.1038/cgt.2012.64 Abstract | Full Text Original Articles Top A novel approach to cancer treatment using structural hybrids of the p53 gene family Y Sasaki, Y Oshima, R Koyama, M Tamura, L Kashima, M Idogawa, T Yamashita, M Toyota, K Imai, Y Shinomura and T Tokino Cancer Gene Ther 2012 19: 749-756; advance online publication, September 7, 2012; 10.1038/cgt.2012.51 Abstract | Full Text Sindbis viral vectors target hematopoietic malignant cells R Suzme, J-C Tseng, B Levin, S Ibrahim, D Meruelo and A Pellicer Cancer Gene Ther 2012 19: 757-766; advance online publication, September 7, 2012; 10.1038/cgt.2012.56 Abstract | Full Text Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells Y Watanabe, Y Hashimoto, S Kagawa, H Kawamura, K Nagai, N Tanaka, Y Urata and T Fujiwara Cancer Gene Ther 2012 19: 767-772; advance online publication, September 7, 2012; 10.1038/cgt.2012.57 Abstract | Full Text MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression Y-S Zang, Y-F Zhong, Z Fang, B Li and J An Cancer Gene Ther 2012 19: 773-778; advance online publication, September 21, 2012; 10.1038/cgt.2012.60 Abstract | Full Text Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liver N Obeng-Adjei, D K Choo, J Saini, J Yan, P Pankhong, A Parikh, J S Chu and D B Weiner Cancer Gene Ther 2012 19: 779-787; advance online publication, October 5, 2012; 10.1038/cgt.2012.61 Abstract | Full Text Efficacy of HER2 retargeted herpes simplex virus as therapy for high-grade glioma in immunocompetent mice E Reisoli, E Gambini, I Appolloni, V Gatta, M Barilari, L Menotti and P Malatesta Cancer Gene Ther 2012 19: 788-795; advance online publication, September 21, 2012; 10.1038/cgt.2012.62 Abstract | Full Text Neural stem cell-based dual suicide gene delivery for metastatic brain tumors C Wang, A Natsume, H J Lee, K Motomura, Y Nishimira, M Ohno, M Ito, S Kinjo, H Momota, K Iwami, F Ohka, T Wakabayashi and S U Kim Cancer Gene Ther 2012 19: 796-801; advance online publication, September 28, 2012; 10.1038/cgt.2012.63 Abstract | Full Text F2A sequence linking MGMTP140K and MDR1 in a bicistronic lentiviral vector enables efficient chemoprotection of haematopoietic stem cells P Maier, D Heckmann, I Spier, S Laufs, M Zucknick, H Allgayer, S Fruehauf, W J Zeller and F Wenz Cancer Gene Ther 2012 19: 802-810; advance online publication, October 5, 2012; 10.1038/cgt.2012.67 Abstract | Full Text Advertisement Ensure your access If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.